Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2021
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
M1. Clinical studies of fungal infections
M1. Clinical studies of fungal infections
M1. Clinical studies of fungal infections
Type here to filter the list
975 - Posaconzole for Treatment of Blastomycosis: An Academic Medical Center’s Experience
Favorite
977 -
Invasive Mucormycosis in a tertiary care hospital, western Saudi Arabia: 11-year retrospective chart review, from 2009 – 2019
Favorite
978 - Disease Associations and Outcomes in Hospitalized Patients with Non-Cutaneous Mucormycosis: Data from the National Inpatient Sample
Favorite
980 - Universal lifelong fungal prophylaxis and risk of coccidioidomycosis in lung transplant recipients living in an endemic area
Favorite
981 - An Investigation into Possible Nosocomial Clusters and On-Treatment Resistance Patterns in Candidemia
Favorite
982 -
Effect of Hepatic Impairment on the Safety and Pharmacokinetics of Rezafungin
Favorite
983 -
Outcomes of Candida Bone and Joint Infections in Eight Patients from a Phase 3 Open-label Study (FURI)
Favorite
984 - Diagnostic Utility of Bronchoalveolar Lavage
Pneumocystis jirovecii
DNA Polymerase Chain Reaction Assay in Patients with Hematological Malignancies and Hematopoietic Cell Transplantation
Favorite
986 - Incidence of Invasive Fungal Infections in Previously Untreated Patients with Acute Myeloid Leukemia Receiving Venetoclax and Azacitadine
Favorite
987 - Clinical epidemiology and outcomes of invasive pulmonary aspergillosis as a complication of respiratory viral infection in hospitalized patients
Favorite
988 - Is There Value of Infectious Diseases Consultation in Candidemia? A Single Center Retrospective Review from 2016-2019
Favorite
989 - Isavuconazonium Sulfate Treatment of Blastomycosis: A Case Series
Favorite
990 - Fungal malignant otitis externa: Clinical and therapeutic features
Favorite
992 -
Oral Ibrexafungerp Outcomes in Patients with Oropharyngeal and Esophageal Candidiasis from an Interim Analysis of a Phase 3 Open-label Study (FURI)
Favorite
Back to Top